URAEUS LAB
The computed 12-month bankruptcy probability of URAEUS LAB is 0.2% (very low). The 2024 annual accounts show equity of €864k and a net result of €230k. Equity is growing by ~46.5% per year across the filed fiscal years. Its solvency ranks better than 88% of 6549 sector peers (fiscal year 2024). The company has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €864k |
| Net result | €230k |
| Staff (FTE) | 1 |
| Better than sector | 88% |
Exceptional profile, strong across almost every axis.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.
See plans →How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 91.4% | 66.7% | |
| Net result | €230k | €46k | |
| Equity | €864k | €79k | |
| Gross operating margin | €387k | €78k | |
| Staff costs | €20k | €21k |
| Fiscal year | 2024 |
|---|---|
| Revenue | - |
| EBITDA | €345k |
| Net profit | €230k |
| Cash flow | €274k |
| Staff costs | €20k |
| Income taxes | €73k |
| Dividends | - |
| Total assets | €945k |
| Equity | €864k |
| Debt | €81k |
| of which ≤ 1y | €81k |
| of which > 1y | - |
| Working capital | €560k |
| Employees (FTE) | 1.0 |
| 2024 | |
|---|---|
| Current ratio | 7.92 |
| Quick ratio | 7.92 |
| Working capital ratio | 59.2% |
| Solvency | 91.4% |
| Debt / equity | 0.09 |
| Long-term debt ratio | - |
| Interest coverage | 3589.42 |
| Gross margin | - |
| Net margin | - |
| ROA | 24.4% |
| ROE | 26.6% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €945k |
| Fixed assets | 21/28 | €305k |
| Tangible fixed assets | 22/27 | €305k |
| Financial fixed assets | 28 | €205 |
| Current assets | 29/58 | €640k |
| Amounts receivable within one year | 40/41 | €181k |
| Cash & bank | 54/58 | €459k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €945k |
| Equity | 10/15 | €864k |
| Contributions / capital | 10/11 | €5k |
| Reserves | 13 | €360k |
| Accumulated profits (losses) | 14 | €499k |
| Amounts payable | 17/49 | €81k |
| Amounts payable within one year | 42/48 | €81k |
| Trade debts payable within one year | 44 | €6k |
| Income statement | ||
| Gross operating margin | 9900 | €387k |
| Operating result | 9901 | €301k |
| Financial income | 75 | €1k |
| Financial charges | 65 | €96 |
| Result before taxes | 9903 | €303k |
| Income taxes | 67/77 | €73k |
| Net result for the period | 9904 | €230k |
| Result to be appropriated | 9905 | €230k |
| NACE primary | Human health(86910) |
| Legal form | Private limited company(610) |
| Incorporation | 16-06-2021 |
| Status | Active |
| Postal code | 6662 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 82028C0506/00V000 | Wallonia | 2,023 m² | 1 · 537 m² | 16.3 m · 2 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
05-12-2023 2 directors appointed
- Laura Thévenin, Commissaris
- Olivier Rossignon, Dagelijks bestuur
Technical details
{
"events": [
{
"kind": "commissaris_in",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Laura Th\u00E9venin",
"address": "9, Les Evets, 6840 Warmifontaine",
"birth_date": "1989-05-31",
"profession": null,
"birth_place": "Virton"
},
"reason": null,
"subkind": "regular",
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "delegation_dagelijks_bestuur_in",
"role": "dagelijks_bestuur",
"person": {
"rrn": null,
"name": "Olivier Rossignon",
"address": "5 rue du mus\u00E9e, 6743 Buzenol",
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "regular",
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": "Vissoule",
"is_associated": false
},
"act_meta": {
"language": "mixed",
"pub_date": "2023-12-05",
"filing_date": null,
"act_kind_objet": "Objet de l\u0027acte:"
},
"decisions": [
{
"body": "algemene_vergadering",
"date": "2023-09-07",
"unanimous": null
}
],
"is_correction": false,
"subject_company": {
"kbo": "0769.756.564",
"name_full": "URAEUS LAB",
"legal_form": "SRL"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Olivier Rossigon",
"org_rep_person_name": null,
"person_role_at_subject": "Expert-comptable"
},
"co_filed_documents": [
"le PV d\u0027AGE du 07/09/2023"
],
"corrected_publication_numac": null
}02-05-2023 Publication in the Belgian Official Gazette, Minor change
Technical details
{
"notary": {
"name": "Caroline RUELLE",
"firm_city": null,
"firm_name": null,
"office_city": "Neufch\u00E2teau",
"is_associated": false
},
"act_meta": {
"language": "fr",
"pub_date": "2023-05-02",
"filing_date": "2023-04-27",
"act_kind_objet": "OBJET"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"date": "2023-04-26",
"unanimous": true
},
"agm_change": {
"new_schedule": null,
"old_schedule": null,
"effective_from_year": null,
"rule_changes_summary": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale ne peut d\u00E9lib\u00E9rer sur une modification de l\u0027objet social que lorsque les actionnaires pr\u00E9sents ou repr\u00E9sent\u00E9s repr\u00E9sentent au moins la moiti\u00E9 du nombre total d\u0027actions \u00E9mises et une modification n\u0027est adopt\u00E9e que si elle a r\u00E9uni quatre cinqui\u00E8mes des voix. Pour les modifications des statuts, le quorum est la moiti\u00E9 des actions \u00E9mises et l\u0027adoption n\u00E9cessite trois quarts des voix."
},
"detected_kind": "agm_rescheduling",
"other_address": null,
"mandate_renewal": null,
"subject_company": {
"kbo": "0769.756.564",
"name_full": "URAEUS LAB",
"legal_form": "SRL"
},
"accounts_deposit": null,
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null
},
"co_filed_documents": [
"Bijlagen bij het Belgisch Staatsblad - 02/05/2023 - Annexes du Moniteur belge"
],
"fiscal_year_change": null,
"liquidation_closure": null,
"officer_designation": null,
"special_procuration": null,
"is_volet_a_only_stub": false,
"vakbekwaamheid_change": null,
"should_reroute_to_category": null,
"single_shareholder_declaration": null
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameFR | URAEUS LAB |